Tredje AP-fonden’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-25,038
| Closed | -$4.6M | – | 278 |
|
2021
Q2 | $4.6M | Hold |
25,038
| – | – | 0.09% | 132 |
|
2021
Q1 | $3.83M | Hold |
25,038
| – | – | 0.09% | 143 |
|
2020
Q4 | $3.91M | Hold |
25,038
| – | – | 0.1% | 141 |
|
2020
Q3 | $2.87M | Hold |
25,038
| – | – | 0.09% | 134 |
|
2020
Q2 | $2.81M | Sell |
25,038
-18,288
| -42% | -$2.05M | 0.12% | 127 |
|
2020
Q1 | $3.89M | Buy |
43,326
+2,693
| +7% | +$242K | 0.2% | 101 |
|
2019
Q4 | $4.39M | Sell |
40,633
-1,972
| -5% | -$213K | 0.22% | 116 |
|
2019
Q3 | $4.17M | Sell |
42,605
-3,380
| -7% | -$331K | 0.2% | 132 |
|
2019
Q2 | $6.02M | Buy |
45,985
+2,245
| +5% | +$294K | 0.29% | 77 |
|
2019
Q1 | $5.91M | Buy |
43,740
+1,512
| +4% | +$204K | 0.31% | 77 |
|
2018
Q4 | $4.11M | Sell |
42,228
-29,918
| -41% | -$2.91M | 0.25% | 97 |
|
2018
Q3 | $10M | Sell |
72,146
-12,885
| -15% | -$1.79M | 0.48% | 48 |
|
2018
Q2 | $10.6M | Buy |
85,031
+11,180
| +15% | +$1.39M | 0.37% | 76 |
|
2018
Q1 | $8.23M | Buy |
73,851
+4,600
| +7% | +$513K | 0.29% | 87 |
|
2017
Q4 | $8.28M | Hold |
69,251
| – | – | 0.28% | 89 |
|
2017
Q3 | $9.72M | Buy |
69,251
+1,075
| +2% | +$151K | 0.34% | 75 |
|
2017
Q2 | $8.3M | Hold |
68,176
| – | – | 0.31% | 75 |
|
2017
Q1 | $8.27M | Hold |
68,176
| – | – | 0.33% | 71 |
|
2016
Q4 | $8.34M | Sell |
68,176
-1,200
| -2% | -$147K | 0.35% | 66 |
|
2016
Q3 | $8.5M | Sell |
69,376
-2,711
| -4% | -$332K | 0.38% | 62 |
|
2016
Q2 | $8.42M | Sell |
72,087
-2,627
| -4% | -$307K | 0.38% | 60 |
|
2016
Q1 | $10.4M | Buy |
74,714
+6,281
| +9% | +$872K | 0.47% | 49 |
|
2015
Q4 | $13.1M | Sell |
68,433
-35,805
| -34% | -$6.83M | 0.84% | 27 |
|
2015
Q3 | $16.3M | Buy |
104,238
+58,453
| +128% | +$9.14M | 1.59% | 11 |
|
2015
Q2 | $7.84M | Buy |
+45,785
| New | +$7.84M | 0.63% | 39 |
|